- Home
- LZM vs DNA Comparison
LZM vs DNA Comparison
Compare LZM & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZM
- DNA
- Stock Information
- Founded
- LZM 2021
- DNA 2008
- Country
- LZM Isle of Man
- DNA United States
- Employees
- LZM N/A
- DNA N/A
- Industry
- LZM Metal Mining
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LZM Basic Materials
- DNA Health Care
- Exchange
- LZM Nasdaq
- DNA Nasdaq
- Market Cap
- LZM N/A
- DNA 466.4M
- IPO Year
- LZM N/A
- DNA N/A
- Fundamental
- Price
- LZM $3.55
- DNA $7.87
- Analyst Decision
- LZM Strong Buy
- DNA Sell
- Analyst Count
- LZM 1
- DNA 5
- Target Price
- LZM $14.00
- DNA $17.25
- AVG Volume (30 Days)
- LZM 145.7K
- DNA 1.3M
- Earning Date
- LZM 05-20-2025
- DNA 05-06-2025
- Dividend Yield
- LZM N/A
- DNA N/A
- EPS Growth
- LZM N/A
- DNA N/A
- EPS
- LZM N/A
- DNA N/A
- Revenue
- LZM $140,522.00
- DNA $237,417,000.00
- Revenue This Year
- LZM $611.56
- DNA N/A
- Revenue Next Year
- LZM $344.44
- DNA $16.74
- P/E Ratio
- LZM N/A
- DNA N/A
- Revenue Growth
- LZM N/A
- DNA 13.76
- 52 Week Low
- LZM $2.90
- DNA $5.00
- 52 Week High
- LZM $9.51
- DNA $38.60
- Technical
- Relative Strength Index (RSI)
- LZM 50.68
- DNA 54.95
- Support Level
- LZM $3.49
- DNA $6.42
- Resistance Level
- LZM $3.71
- DNA $7.71
- Average True Range (ATR)
- LZM 0.22
- DNA 0.62
- MACD
- LZM 0.08
- DNA 0.01
- Stochastic Oscillator
- LZM 80.65
- DNA 70.73
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.